| Medical and Health Sciences | 2021-2025 | 567 | KR 5 | 99.88 |
| Epidemiology | Lifetime | 211 | KR 1 | 99.73 |
| Neuroscience of Neurology | Lifetime | 75 | KR 1 | 99.39 |
| Hepatology | Lifetime | 106 | KR 2 | 99.26 |
| Developmental Neuroscience | Lifetime | 46 | KR 1 | 98.71 |
| Cellular and Molecular Neuroscience | Lifetime | 525 | KR 1 | 98.02 |
| Clinical Neurology | Lifetime | 989 | KR 7 | 93.38 |
| Medical Genetics | Lifetime | 822 | KR 8 | 89.84 |
| Biotechnology | Lifetime | 862 | KR 18 | 76.36 |
| Epidemiology | 2021-2025 | 47 | KR 1 | 99.74 |
| Hepatology | 2021-2025 | 47 | KR 2 | 98.83 |
| Liver Disease Diagnosis and Treatment | Lifetime | 108 | KR 2 | 99.81 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 61 | KR 1 | 99.66 |
| Hepatitis B Virus Studies | Lifetime | 97 | KR 2 | 99.66 |
| Neurogenesis and neuroplasticity mechanisms | Lifetime | 58 | KR 1 | 99.58 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 108 | KR 10 | 99.53 |
| Hepatitis C virus research | Lifetime | 136 | KR 3 | 99.56 |
| Liver Disease and Transplantation | Lifetime | 143 | KR 4 | 99.50 |
| Pluripotent Stem Cells Research | Lifetime | 89 | KR 1 | 99.23 |
| Immune cells in cancer | Lifetime | 170 | KR 1 | 98.91 |
| Nerve injury and regeneration | Lifetime | 120 | KR 1 | 99.08 |
| Cancer Research and Treatments | Lifetime | 247 | KR 2 | 98.40 |
| Mesenchymal stem cell research | Lifetime | 254 | KR 5 | 98.61 |
| RNA Interference and Gene Delivery | Lifetime | 704 | KR 12 | 98.23 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 411 | KR 38 | 98.29 |
| Diet, Metabolism, and Disease | Lifetime | 380 | KR 6 | 98.06 |
| Liver Diseases and Immunity | Lifetime | 232 | KR 3 | 98.06 |
| Cancer, Lipids, and Metabolism | Lifetime | 678 | KR 4 | 97.59 |
| Adenosine and Purinergic Signaling | Lifetime | 822 | KR 7 | 93.50 |
| Cancer Mechanisms and Therapy | Lifetime | 819 | KR 24 | 92.78 |
| Nuclear Receptors and Signaling | Lifetime | 871 | KR 17 | 90.04 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 60 | KR 2 | 99.60 |
| Hepatitis B Virus Studies | 2021-2025 | 21 | KR 2 | 99.38 |
| Hepatitis C virus research | 2021-2025 | 27 | KR 2 | 99.40 |
| Liver Disease and Transplantation | 2021-2025 | 79 | KR 1 | 99.14 |
| Diet, Metabolism, and Disease | 2021-2025 | 61 | KR 2 | 98.25 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 221 | KR 21 | 97.39 |
| Liver Diseases and Immunity | 2021-2025 | 101 | KR 2 | 96.11 |
| Alcohol Consumption and Health Effects | 2021-2025 | 171 | KR 11 | 92.87 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 822 | KR 20 | 85.17 |
| Liver physiology and pathology | 2021-2025 | 395 | KR 14 | 79.62 |
